Technology and Health Care

Share this journal
impact factor 2020 0.806
ISSN print
0928-7329
ISSN online
1878-7401
Volume
29; 6 issues
Status
Last issue (29:3) online on 21 May 2021
Next issue
29:4 scheduled for July 2021
Back volumes
1-28
Subject
Biochemistry, Medicine & Health, Rehabilitation & Assistive Technology
INSTITUTIONAL SUBSCRIPTION FOR 2021 €625 / US$794 Excluding VAT
Subscribe to Online

Technology and Health Care is intended to serve as a forum for the presentation of original articles and technical notes, observing rigorous scientific standards. Furthermore, upon invitation, reviews, tutorials, discussion papers and minisymposia are featured. The main focus of THC is related to the overlapping areas of engineering and medicine. The following types of contributions are considered:

  1. Original articles: New concepts, procedures and devices associated with the use of technology in medical research and clinical practice are presented to a readership with a widespread background in engineering and/or medicine. In particular, the clinical benefit deriving from the application of engineering methods and devices in clinical medicine should be demonstrated. Typically, full length original contributions have a length of 4000 words, thereby taking duly into account figures and tables.
  2. Technical Notes and Short Communications: Technical Notes relate to novel technical developments with relevance for clinical medicine. In Short Communications, clinical applications are shortly described. Both Technical Notes and Short Communications typically have a length of 1500 words.
  3. Reviews and Tutorials (upon invitation only): Tutorial and educational articles for persons with a primarily medical background on principles of engineering with particular significance for biomedical applications and vice versa are presented. The Editorial Board is responsible for the selection of topics.
  4. Minisymposia (upon invitation only): Under the leadership of a Special Editor, controversial or important issues relating to health care are highlighted and discussed by various authors.
  5. Letters to the Editors: Discussions or short statements (not indexed).

Specific topics relating to medical and biological engineering within the journal’s scope are:

  • Bioelectronics, clinical biomechanics, biophotonics
  • Medical imaging technology, bio-imaging
  • Surgical technology
  • Monitoring devices, respiration technology, drug delivery systems
  • Diagnostic and therapeutic procedures associated with Ionizing and non-ionizing radiation
  • Artificial organs, biomaterials
  • Tissue engineering, bio-inspired materials, molecular and cellular methods
  • Devices and instruments for use in rehabilitation
  • Telemedicine, e-health and mobile phone techniques for use in clinical medicine
  • Home care technology

Note: In consideration of the rapid development of medical IT, the description of computer programs, in particular of AI and machine learning procedures, exhibiting screen shots, explicit computer code, etc. is not accepted for publication because of imminent obsoleteness. Likewise, for the same reason, computer-based image or biological signal analysis procedures without demonstration of long-lasting clinical relevance are not suited for publication. Furthermore, the presentation of surveys and questionnaire projects, often with local participation only, is not in agreement with the aims & scope of the journal.

Editors-in-Chief
Prof. em. Peter F. Niederer
Nordstrasse 366
CH-8037 Zurich
Switzerland
Tel.: +41 1 632 45 68
Fax: +41 1 632 11 93
Email: niederer@ethz.ch

PD Dr. Matthias Lahner
Joint Center Hilden
Ruhr University Bochum
Bahnhofsallee 20
40721 Hilden
Germany
Tel.: +49 2103-2590140
Fax: +49 2103-2590179
Email: lahner@gelenkzentrum-hilden.de

Past Editor-in-Chief
Prof. Ali E. Engin, 1999-2005

Deputy Editors-in-Chief
Bolanle Asiyanbola
Associate Professor of Surgery
Meharry Medical College
Nashville, TN 37248
USA
Email: basiyan@hotmail.com

Makoto Ohta
Biomedical Flow Dynamics Lab.
Creative Flow Research Div.
Institute of Fluid Science
Tohoku University
Sendai, Miyagi
Japan
Email: ohta@biofluid.ifs.tohoku.ac.jp

Section Editors
Public Health, Health Information Systems
Ram Bhagyalakshmi, PSNA College Of
Engineering and Technology,
Kothandaraman Nagar, India

Orthopedics, Arthroscopic Joint Surgery
Wolfram Teske, Ruhr University
Bochum, Bochum, Germany

Clinical Engineering, Health Technology Management, Human Factor Engineering
Roberto Miniati, University of Florence,
Florence, Italy

E-health
Christos N. Schizas, University of Cyprus, Nicosia, Cyprus

M-health
Melvyn Zhang Weibin, National University of Singapore, Singapore, Singapore

Editorial Board
Almir Badnjevic, University of Sarajevo, Sarajevo Bosnia and Herzegovina
Shanmugam Balamurugan, Intelligent Research Consultancy
Services, Coimbatore, India
Elizabeth Bell Brokaw, MITRE Health, McLean, VA, USA
Gerardo Catapano, University of Calabria, Rende, Italy
Mustafa Citak, Helios ENDO Clinic Hamburg, Hamburg, Germany
Sara Condino, University of Pisa, Pisa, Italy

Editorial Board (cont’d.)
James A. Covington, University of Warwick, Coventry, UK
Sebastian Dendorfer, Regensburg University of Applied Sciences, Regensburg, Germany
Mark Donnelly, Ulster University, Newtownabbey, UK
Garry Duffy, Royal College of Surgeons in Ireland (​RCSI), Dublin, Ireland
Christian Duif, St. Josef-Hospital, Bochum, Germany
David Elad, Tel Aviv University, Tel Aviv, Israel
Juan Fang, Bern University of Applied Sciences, Bern, Switzerland
Chiara Giulia Fontanella, University of Padova, Padova, Italy
Francesco Frosini, University of Florence, Florence, Italy
Josef Guttmann, Freiburg University Hospital - Anesthesiology and Intensive Care, Freiburg, Germany
Joachim Hammer, Regensburg University of Applied Sciences, Regensburg, Germany
Jungsoo Han, Baekseok University, Cheonan, Korea
Peter Hilfiker, Swiss Epilepsy Centre, Zurich, Switzerland
Kenneth J. Hunt, Bern University of Applied Sciences, Bern, Switzerland
Christine Huttin, Aix-Marseille University, Marseille, Belgium
M. Sriram Iyengar, University of Texas Health Science Center at Houston, Houston, TX, USA
Yizhang Jiang, Jiangnan University, Wuxi, China
Ashish Joshi, University of Nebraska Medical Center, Omaha, NE, USA
Cathal Kearney, Royal College of Surgeons in Ireland, Dublin, Ireland
Min Soon Kim, University of Missouri School of Medicine, Columbia, MO, USA
Melissa L. Knothe Tate, Case Western Reserve University, Cleveland, OH, USA
Dimitris Koutsouris, National Technical University of Athens, Athens, Greece
Gregorij Kurillo, University of California - Berkeley, Berkeley, CA, USA
Adam Liebert, Polish Academy of Sciences, Warsaw, Poland
Dieter Liepsch, Munich University of Applied Sciences, Munich, Germany
Paul Peter Lunkenheimer, University Hospital Muenster, Muenster, Germany
Frank Lyons, St. James's Hospital, Dublin, Ireland
Peter Manser, ETH Zurich, Zurich, Switzerland Zlatko Matjacic, University Rehabilitation Institute, Ljubljana, Slovenia
Paul J. McCullagh, Ulster University, Newtownabbey, UK
Matjaz Mihelj, University of Ljubljana, Ljubljana, Slovenia
Marina Milosevic, University of Kragujevac, Kragujevac, Serbia
Hamidreza Namazi, Monash University Malaysia, Selangor, Malaysia
Stanislav Polzer, Technical University of Ostrava, Ostrava, Czech Republic
Richard Reilly, Trinity College, Dublin, Ireland
Vladimir Rogalewicz, Czech Technical University in Prague, Prague, Czech Republic
Jude P.J. Savarraj, University of Texas Health Science Center at Houston, Houston, TX, USA
Amulya K. Saxena, Imperial College London, London, UK
Kai-Uwe Schmitt, AGU Zurich, Zurich, Switzerland
Neeru Sharma, University of Nebraska Medical Center, Omaha, NE, USA
Ayush Singhal, University of Minnesota Twin Cities, Minneapolis, MN, USA
Jess G. Snedeker, University of Zurich, Zurich, Switzerland
Ling Sun, Zimmer Inc., Warsaw, IN, USA
Nirmalya Thakur, University of Cincinnati, Cincinnati, OH, USA
Mohy Uddin, King Saud bin Abdul Aziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia
Bart G.J. Verkerke, University of Groningen, Groningen, The Netherlands
Xiaoxi Yang, BioMedomics, Inc., Durham, NC, USA
Ting Ye, Advanced Cell Diagnostics, Inc., Hayward, CA, USA
Kelvin Yeung, The University of Hong Kong Medical Centre, Hong Kong, China
Yudong Zhang, University of Leicester, Leicester, UK

SUBMISSION OF MANUSCRIPT

By submitting my article to this journal, I agree to the IOS Press License to Publish: https://www.iospress.nl/service/authors/author-copyright-agreement/ and the IOS Press Privacy Policy: https://www.iospress.nl/privacy-policy/.

Authors are requested to submit their manuscript electronically to the journal’s editorial management system.
Authors may include a positive and negative list of possible reviewers in the cover letter of their submission.

Note that the manuscript should be uploaded as one file with tables and figures included. This file can be a Word document, a PDF, or a zip file.

Please take a moment to read the IOS Press general publication ethics guideline before submitting your manuscript.

Publication Fee
Please note that for articles that are submitted and accepted from 1 January 2017, authors will be required to pay a publication fee of €300/US$340 for full length papers and €150/US$175 for short papers. For articles submitted and accepted after 1 September 2018, authors will be required to pay a publication fee of €350/$400, regardless of the type of paper.

A waiver request for the publication fee should be submitted before the initial submission of a paper. Please send your title, abstract, keyword list and author list including affiliations (and if available ORCID IDs) to the Editors-in-Chief, along with your motivation for the waiver. Your request will be evaluated by the editorial office.

Required files for final submissions
After the article has been accepted, the authors should submit the final version as source files, including a word processor file of the text, such as Word or LateX (If using LaTeX, please use the standard article.sty as a style file and also send a PDF version of the LaTeX file).

Colour figures
It is possible to have figures printed in colour, provided the cost of their reproduction is paid for by the author. See Preparation of Manuscripts for the required file formats.

Open Access option
The IOS Press Open Library® offers authors an Open Access (OA) option. By selecting the OA option, the article will be freely available from the moment it is published, also in the pre-press module. In the Open Library® the article processing charges are paid in the form of an Open Access Fee. Authors will receive an Open Access Order Form upon acceptance of their article. Open Access is entirely optional. See also our website for more information about this option IOS Press Open Library®

PREPARATION OF MANUSCRIPTS

Organization of the paper and style of presentation

Manuscripts must be written in English. Authors whose native language is not English are advised to seek the advice of a native English speaker, before submitting their manuscripts. Peerwith offers a language and copyediting service to all scientists who want to publish their manuscript in scientific peer-reviewed periodicals and books. Manuscripts should be prepared with wide margins and double spacing throughout, including the abstract, footnotes and references. Every page of the manuscript, including the title page, references, tables, etc., should be numbered. However, in the text no reference should be made to page numbers; if necessary, one may refer to sections. Try to avoid the excessive use of italics and bold face. Manuscripts should be organized in the following order:

  • Title page
  • Body of text (divided by subheadings)
  • Acknowledgements
  • References
  • Tables
  • Figure captions
  • Figures
  • Headings and subheadings should be numbered and typed on a separate line, without indentation. SI units should be used, i.e., the units based on the metre, kilogramme, second, etc.

    Title page
    The title page should provide the following information:

  • Title (should be clear, descriptive and not too long)
  • Name(s) of author(s); please indicate who is the corresponding author
  • Full affiliation(s)
  • Present address of author(s), if different from affiliation
  • Complete address of corresponding author, including tel. no., fax no. and e-mail address
  • Abstract
  • Keywords
  • Abstract
    The abstract should be clear, descriptive, self-explanatory and not longer than 200 words, it should also be suitable for publication in abstracting services. The abstract for research papers should follow the “structured abstract” format. Section labels should be in bold uppercase letters followed by a colon, and each section will begin on a new line.

    BACKGROUND:
    OBJECTIVE:
    METHODS:
    RESULTS:
    CONCLUSIONS:


    Tables
    Number as Table 1, Table 2 etc, and refer to all of them in the text. Each table should be provided on a separate page of the manuscript. Tables should not be included in the text. Each table should have a brief and self-explanatory title. Column headings should be brief, but sufficiently explanatory. Standard abbreviations of units of measurement should be added between parentheses. Vertical lines should not be used to separate columns. Leave some extra space between the columns instead. Any explanations essential to the understanding of the table should be given in footnotes at the bottom of the table.

    REFERENCES

    Authors are requested to use the Vancouver citation style. Place citations as numbers in square brackets in the text. All publications cited in the text should be presented in a list of references at the end of the manuscript. List the references in the order in which they appear in the text. Only articles published or accepted for publication should be listed in the reference list. Submitted articles can be listed as (author(s), unpublished data). If an article has a DOI, this should be provided after the page number details. The number is added after the letters 'doi'. Manuscripts will not be considered if they do not conform to the Vancouver citation guidelines. References must be listed in Vancouver style: [1] Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002; 935(12): 406. [2] Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002. [3] Berkow R, Fletcher AJ, editors. The Merck manual of diagnosis and therapy. 16th ed. Rahway (NJ): Merck Research Laboratories; 1992. [4] Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGrawHill; 2002. p. 93113. [5] Canadian Cancer Society [homepage on the Internet]. Toronto: The Society; 2006 [updated 2006 May 12; cited 2006 Oct 17]. Available from: www.cancer.ca/.

    Footnotes
    Footnotes should only be used if absolutely essential. In most cases it is possible to incorporate the information in the text. If used, they should be numbered in the text, indicated by superscript numbers and kept as short as possible.

    COPYRIGHT

    Copyright of your article
    Authors submitting a manuscript do so on the understanding that they have read and agreed to the terms of the IOS Press Author Copyright Agreement.

    Quoting from other publications
    An author, when quoting from someone else's work or when considering reproducing figures or table from a book or journal article, should make sure that he is not infringing a copyright. Although in general an author may quote from other published works, he should obtain permission from the holder of the copyright if he wishes to make substantial extracts or to reproduce tables, plates or other figures. If the copyright holder is not the author of the quoted or reproduced material, it is recommended that the permission of the author should also be sought. Material in unpublished letters and manuscripts is also protected and must not be published unless permission has been obtained. Submission of a paper will be interpreted as a statement that the author has obtained all the necessary permission. A suitable acknowledgement of any borrowed material must always be made.

    PROOFS

    The corresponding author will receive a PDF proof and is asked to check this proof carefully (the publisher will execute a cursory check only). Corrections other than printer's errors, however, should be avoided. Costs arising from such corrections will be charged to the authors.

    PURCHASES

    How to order reprints, a PDF file, journals, or IOS Press books
    The corresponding author of a contribution to the journal will receive a complimentary PDF Author’s Copy of the article, unless otherwise stated. This PDF copy is watermarked and for personal use only. A free PDF copy will not be provided for conference proceedings and abstract issues. An order form for a PDF file without watermark, reprints or additional journal copies will be provided along with the PDF proof.

    If you wish to order reprints of an earlier published article, please contact the publisher for a quotation. IOS Press, Fax: +31 20 687 0019. Email: editorial@iospress.nl.

    An author is entitled to 25% discount on IOS Press books. See Author's discount (25%) on all IOS Press book publications.

    KUDOS


    Authors of published articles (non-prepress, final articles) will be contacted by Kudos. Kudos is a service that helps researchers maximize the impact and visibility of their research. It allows authors to enrich their articles with lay metadata, add links to related materials and promote their articles through the Kudos system to a wider public. Authors will receive no more than three emails: one invitation and a maximum of two reminders to register for the service and link the published article to their profile. Using and registering for Kudos remains entirely optional. For more information, please have a look at our authors section.

    HOW TO PROMOTE YOUR WORK

    Would you like some pointers on how to help your research achieve a wider reach and greater impact? Please consult our Promotional Toolkit for Authors for tips.

     

    Academic Source Complete
    ACM Digital Library
    Cabell's Guide or Directory
    CSA Illumina
    DBLP Bibliography Server
    EBSCO databases
    EBSCO Databases
    Embase
    EMBIO
    Google Scholar
    Health & Safety Science Abstracts
    Inspec IET
    MEDLINE
    Pubmed Central
    Science & Technology Collection
    Scopus
    Ulrich's Periodicals Directory
    Under Evaluation APA
    Web of Science: Science Citation Index-Expanded (SciSearch®)

    No Need to Steer Clear of Electric Cars If You Have a Pacemaker

    07 Apr 2020 - Amsterdam, NL – A study published in Technology and Health Care shows that four leading brands of e-cars do not trigger electromagnetic interference (EMI) with cardiac implantable electronic devices (CIED). CIEDs like pacemakers and defibrillators may malfunction when they are exposed to strong electromagnetic fields (EMF) generated by powerful motors. While rare events, such errors could have serious consequences for patients. With the increasing use of electric-powered vehicles for public and private transport, there is a critical need to assess the potential risks for this population....

    Technology and Health Care Peer Review Policy

    Technology and Health Care is a peer-reviewed journal. Articles submitted to the journal undergo a single-blind peer review process. This means that the identity of the authors is known to the reviewers but the identity of the reviewers is not communicated to the authors.

    All submitted manuscripts are subjected to initial appraisal by the Editors-in-Chief and, if found suitable for further consideration, to rigorous peer review by independent, anonymous expert referees. Reasons to reject a paper in the pre-screening process could for example be that the work does not fall within the aims and scope, the writing is of poor quality, the instructions to authors were not followed or the presented work is not novel.

    Papers deemed suitable to be reviewed will be assigned to a handling editor. The handling editor will then invite reviewers to comment on the work and might consider inviting the reviewers suggested by the author(s). Editors and reviewers are asked to excuse themselves from reviewing a submission if a conflict of interest makes them unable to make an impartial scientific judgment or evaluation. Conflicts of interest include but are not limited to: collaboration with the authors in the past three years; any professional or financial affiliations that may be perceived as a conflict of interest; a history of personal differences with the author(s).

    As a standard policy, decisions are based on two reviews, in some specific circumstances one review may be deemed sufficient to make a decision on a paper. The Editors-in-Chief strive to ensure a typical turnaround time of three months.

    Reviewers are asked to judge a paper on at least:

    • Logical, concise ordering of ideas
    • Use of sound research methods
    • Adequacy of documentation
    • Material has good applied use in the field
    • Readability and interest level

    Based on the received reviews the handling editor will propose to the Editors-in-Chief a recommendation:

    1. Accept article as submitted
    2. Accept article revision by the author according to suggestions made in review
    3. Revise and resubmit
    4. Reject
    5. Consider for another issue/publication

    They mean the following:

    1. The manuscript is suitable for publication and only requires minor polishing; thus, no further reviews are requested.
    2. The authors are required to make moderate changes to their manuscript. The manuscript becomes acceptable for publication if the changes proposed by the reviewers and editors are successfully addressed. The revised manuscript will be examined by the Editors-in-Chief and possibly sent back to all (or a selection of) reviewers for a second round of reviews. Authors are requested to provide a letter to the reviewers detailing the improvements made for the resubmission.
    3. In its current form, the manuscript is not suitable for publication. A resubmission would require substantial revisions and is only encouraged in special cases. The resubmitted manuscript will be considered as a new submission.
    4. The manuscript is rejected as it is deemed to be out of scope, not relevant, or not meeting the journal’s quality standards in terms of significance, novelty, and/or presentation.
    5. The manuscript is rejected as it is deemed to be better suited for a different journal or publication.

    Authors are notified by the Editors-in-Chief, whose decision is final.